Search for: "Eli Lilly "
Results 801 - 820
of 2,131
Sort by Relevance
|
Sort by Date
25 Apr 2014, 8:17 am
The jury found that Takeda was 75% liable and Eli Lilly was 25% liable, and split the punitive award accordingly – $6 billion against Takeda and $3 billion against Lilly. [read post]
25 Apr 2014, 8:17 am
The jury found that Takeda was 75% liable and Eli Lilly was 25% liable, and split the punitive award accordingly – $6 billion against Takeda and $3 billion against Lilly. [read post]
24 Apr 2014, 9:55 pm
Eli Lilly and Company et al. v. [read post]
24 Apr 2014, 12:30 pm
Onglyza is a DPP-4 inhibitor, a class of drugs that also includes Merck's Januvia (sitagliptin), Eli Lilly and Boehringer Ingelheim's Tradjenta/Trajenta (linagliptin) and Takeda's Nesina (alogliptin). [read post]
24 Apr 2014, 10:17 am
According to Eli Lilly and Co., 75 percent of the liability was allocated to Takeda and 25 percent to Lilly. [read post]
23 Apr 2014, 6:47 pm
See Eli Lilly & Co. v. [read post]
18 Apr 2014, 1:29 pm
The Osaka-Japan based company may be forced to pay the final judgment in the case, even covering the $3 billion ordered paid by its partner company Eli Lilly in Indianapolis. [read post]
16 Apr 2014, 5:35 am
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Researchers have long suspected a link between testosterone treatment and the risk of heart attack, though millions of men who have been taking the hormonal treatments are just now… [read post]
15 Apr 2014, 9:53 am
See the post Eli Lilly vs. [read post]
14 Apr 2014, 2:36 pm
Eli Lilly & Co., No. 2:12-247-DCR (E.D. [read post]
14 Apr 2014, 7:52 am
Jury Says Takeda and Eli Lilly Must Pay $9 Billion for Actos Bladder Cancer Japanese pharmaceutical manufacturer Takeda Pharmaceutical and their US distributor Eli Lilly have been ordered to pay $9 billion in punitive damages after a federal court ruled that the companies hid potential cancer risks associated with taking Actos to treat Type 2 diabetes. [read post]
13 Apr 2014, 2:40 pm
The court also ordered Takeda’s U.S. partner, Eli Lilly, which marketed the drug in this country, to pay $3 billion. [read post]
11 Apr 2014, 7:57 am
Both defendants, Takeda Pharmaceuticals Co. and Eli Lilly & Co., insists that their medication is safe and they plan to appeal the jury's verdict. [read post]
10 Apr 2014, 3:43 pm
., ordered the Japanese company, Takeda Pharmaceutical, to pay $6 billion in punitive damages on Monday after finding that the company had hidden the cancer risks of its drug, Actos.The jury also ordered Takeda’s partner, Eli Lilly, which once marketed the drug in the United States, to pay $3 billion.Both Takeda and Lilly said they disagreed with the verdict and would fight it. [read post]
9 Apr 2014, 12:33 pm
At issue for the moment is a $9 Billion punitive damage award against Japan’s Takeda Pharmaceutical and Eli Lilly this week. [read post]
9 Apr 2014, 11:20 am
On Monday, a jury in Louisiana ordered Eli Lilly and Takeda, a Japanese pharmaceutical company, to pay $1.475M in compensatory damages and $9B in punies for concealing cancer risks in the diabetes drug Actos. [read post]
8 Apr 2014, 1:17 pm
Takeda Pharmaceutical Co. and Eli Lilly & Co. [read post]
8 Apr 2014, 10:28 am
” And a jury in Lafayette, Louisiana just ordered Takeda Pharmaceutical and Eli Lilly & Co. [read post]
8 Apr 2014, 8:02 am
Biotechnology Patents Under Attack: From Prometheus to Myriad, the Supreme Court's Narrowing View of Patent Eligible Subject Matter Panel: Jim Kelley, Senior Director-Assistant General Patent Counsel, Eli Lilly and Co; Paul Berghoff (Partner, McDonnell Boehnen Hulbert & Berghoff), Prof. [read post]
5 Apr 2014, 4:25 pm
Thousands of product liability lawsuits have been filed against Takeda Pharmaceuticals and Eli Lilly, the drug mamanufacturers for failure to research the medication and failure to provide sufficient warnings to patients and doctors. [read post]
